page 1
page 2
page 3
page 4
page 5
page 6
page 7
page 8
page 9
page 10
page 11
page 12
page 13
page 14
page 15
page 16
page 17
page 18
page 19
page 20
page 21
page 22
page 23
page 24
page 25
page 26
page 27
page 28
page 29
page 30
page 31
page 32
page 33
page 34
page 35
page 36
page 37
page 38
page 39
page 40
page 41
page 42
page 43
page 44
page 45
page 46
page 47
page 48
page 49
page 50
page 51
page 52
page 53
page 54
page 55
page 56
page 57
page 58
page 59
page 60
page 61
page 62
page 63
page 64
page 65
page 66
page 67
page 68
page 69
page 70
page 71
page 72
page 73
page 74
page 75
page 76
page 77
page 78
page 79
|
62Spire Healthcare Annual Review 2010Spire Healthcare Limited PartnershipNotes to the financial statementsFor the year ended 31 December 201015. Borrowings continuedObligations under finance leasesThe Group has finance leases in respect of three hospital properties. Future minimum lease payments under these finance leases, which expire in 2040, are as follows:20102009Minimum payments £000Present value of payments£000Minimum payments £000Present value of payments £000Within one year6,3513,866--After one year but not more than five years26,17513,318--More than five years197,94356,862--Total minimum lease payments 230,46974,046--Less amounts representing finance charges(156,423)---Present value of minimum lease payments74,04674,046--The property leases with a liability of £74 million mature in 2040 and carry an implicit interest rate of 9.1%.Terms and debt repayment scheduleThe maturity date is the date on which all the bank loans will have been fully repaid.a) The terms and conditions of bank facilities on which there are balances outstanding are as follows:MaturityMargin over LIBORPrincipal drawn 2010£000Carrying amount after issue costs and including interest accrued2010£000Carrying amount after issue costs and including interest accrued2009£000Spire 1Term loan- operating companiesAugust 20142.0%-3.0%115,800110,312112,824Term loan - property companiesOctober 20141.25%-2.35%994,466989,640987,082Capex loanAugust 2014 2.0%38,90838,91034,411PIK notesOctober 20147.05%83,64584,31877,659Spire 2Term loan March 2015-20172.25%-3.5%43,11041,68956,896Mezzanine loanMarch 20189.75%22,77122,78421,476Other loansMarch 20152.25%6,0006,0006,9271,304,700 1,293,653 1,297,275
63Spire Healthcare Limited Partnershipb) The terms and conditions of loans from the ultimate parent undertaking and management are as follows:MaturityInterest ratePrincipal drawn£000Carrying amount after issue costs and including interest accrued2010£000Carrying amount after issue costs and including interest accrued2009£000Ultimate parent undertaking - Spire 1August 203712%487,807503,689449,722Ultimate parent undertaking - Spire 2March 203812%90,25198,13887,521578,058601,827537,243The Group has available the following lines of credit:. £56 million acquisition/capex facilities, of which £11.1 million was undrawn as at 31 December 2010. £55 million revolving credit facilities, of which £17.7 million have been utilised in the form of guarantees, letters of credit and bank loans and £37.3 million was undrawn as at 31 December 201016. Provisions2010£0002009£000At 1 January 2010 1,7901,266Acquired on acquisition314-Charge for the year111,043Utilised during the year(973)(519)At 31 December 2010 1,1421,790The 2010 provision acquired on acquisition relates to leases for the London Fertility Centre. In 2009 other provisions comprised restructuring costs in respect of onerous tenancy contracts for the Manchester office and the onerous tenancy contracts in respect of two regional distribution centres following the decision to centralise warehousing activities to one National Distribution Centre in 2009.
|